The gastroenterology service has been involved with intestinal and hepatic aspects of marrow transplantation for 10 years, providing clinical consultation, performing diagnostic and therapeutic procedures and carrying out clinical research in close collaboration with pathology (Project X.C), virology (Project III), and nutrition (Project X.D.). Consultations involve pre-transplant intestinal problems and a wide range of post-transplant disorders related to chemoradiation toxicity, acute GVHD, enteric and liver infections, side effects of medication, and chronic GVHD. Procedures include upper intestinal endoscopy, mucosal biopsies, coagulation of bleeding sites, esophageal dilation, colonoscopy, percutaneous liver biopsy, and esophageal manometry. Research projects included in this section are studies of hepatic venocclusive disease, intestinal GVHD, and hepatic viral infection. We will analyze the incidence of venocclusive disease (VOD) of the liver and the risk factors associated with this complication. We will conduct a randomized trial of continuous infusion of heparin for the prophylaxis of VOD. We will examine intestinal epithelial cell proliferation in patients with acute GVHD, testing the hypothesis that GVHD damages progenitor crypt cells. We will use immunohistologic methods and electron microscopy to identify a subset of intestinal intraepithelial lymphocytes which may be involved with alloimmune crypt cell destruction in patients with acute GVHD. We will study the relationship of viral infections of the liver and manifestation of GVHD In a prospective study of patients with posttransplant liver dysfunction. An ongoing study of intestinal carbohydrate absorption after transplantation will be continued with emphasis on recovery of intestinal disaccharidase activity following acute intestinal GVHD. These collaborative studies are all carried out in human marrow transplant recipients, with both clinical and research data emanating from consultations and procedures by the gastroenterology section.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA018029-15
Application #
3811913
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334
Shaw, Bronwen E; Syrjala, Karen L; Onstad, Lynn E et al. (2018) PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. Cancer 124:841-849
Jamani, Kareem; Onstad, Lynn E; Bar, Merav et al. (2018) Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2271-2276
Ogimi, Chikara; Xie, Hu; Leisenring, Wendy M et al. (2018) Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2160-2163
Salter, Alexander I; Pont, Margot J; Riddell, Stanley R (2018) Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131:2621-2629
Lee, Stephanie J; Nguyen, Tam D; Onstad, Lynn et al. (2018) Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:555-562
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Armenian, Saro H; Yang, Dongyun; Teh, Jennifer Berano et al. (2018) Prediction of cardiovascular disease among hematopoietic cell transplantation survivors. Blood Adv 2:1756-1764
Petersdorf, Effie W; Stevenson, Philip; Malkki, Mari et al. (2018) Patient HLA Germline Variation and Transplant Survivorship. J Clin Oncol 36:2524-2531
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580

Showing the most recent 10 out of 1845 publications